readthroughSign in
Oct 23, 2026People3 fact check notes

Dr. Reddy's posts lower revenue and profit for quarter ended September 2026

SEC 6-K filing shows the drugmaker's Q2 FY27 revenue and profit both declined from a year earlier, with a Semaglutide inventory charge and a CAR-T asset sale noted.

Dr. Reddy's Laboratories Limited filed a Form 6-K with the SEC on October 23, 2026, covering the quarter and six months ended September 30, 2026. The company said its interim financial statements were authorized for issuance by its Board of Directors on October 23, 2026.1

By segment, quarterly revenue was Rs.77,927 million for Global Generics and Rs.8,310 million for PSAI1, versus Rs.78,498 million and Rs.9,450 million, respectively, in the prior-year quarter1.

The filing disclosed that some Semaglutide batches failed specification because of a problem tied to the active ingredient used in the product, leading the company to record a provision of Rs.2,230 million for inventory and Rs.167 million in other related costs during the three months ended June 30, 20261.

Separately, the company said that it sold certain CAR-T program assets in August 2026 and transferred the related lease to the buyer, which led to a Rs.137 million reversal of previously recorded impairment charges1.

Fact check notes

  • Sentence removedFor the three months ended September 30, 2026, revenue was Rs.86,708 million, down from Rs.88,051 million in the same period a year earlier.a figure with no citation
  • Sentence removedProfit for the period was Rs.9,134 million for the quarter, compared with Rs.14,268 million a year earlier.a figure with no citation
  • Sentence removedFor the six months ended September 30, 2026, revenue came to Rs.167,413 million, versus Rs.173,503 million a year earlier, while profit for the period was Rs.13,482 million compared with Rs.28,364 million.a figure with no citation

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Where the check questioned a sentence, its note is shown above. Not investment advice.